Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups

Diğer sürümleri göster (1)

Detaylı Bibliyografya
Asıl Yazarlar:	Lrrzow, MR, Buck, G, Dewald, G, Fielding, A, Ketterling, R, Lazarus, H, Luger, S, Marks, D, McMillan, A, Moorman, A, Paietta, E, Richards, S, Rowe, J, Tallman, MS, Goldstone, A
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	AMER SOC HEMATOLOGY 2010

Benzer Materyaller

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups
Yazar:: Lrrzow, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups
Yazar:: Lrrzow, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Implications for the Use of Monoclonal Antibodies in Future Adult ALL Trials: Analysis of Antigen Expression in 505 B-Lineage (B-Lin) ALL Patients (pts) on the MRC UKALLXII/ECOG2993 Intergroup Trial.
Yazar:: Paietta, E, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Does imatinib change the outcome in philapdelphia chromosome positive acute lympooblastic leukaemia in adults? Data from the UKALLXII/ECOG2993 study
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial
Yazar:: Ganzel, C, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
Yazar:: Moorman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
Yazar:: Mansour, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
Yazar:: Moorman, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial
Yazar:: David I. Marks, ve diğerleri
Baskı/Yayın Bilgisi: (2013-06-01)

Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph plus) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993).
Yazar:: Goldstone, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Unlike Paediatric T-ALL, Notch-1 and FBXW7 Mutations Do Not Seem to Predict a Better Outcome in Adult Patients: Data from the UKALLXII/ECOG2993 Protocol.
Yazar:: Mansour, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
Yazar:: Ramanujachar, R, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).
Yazar:: Marks, D, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Transplant: An Analysis from ECOG 2993/MRC UK ALLXII.
Yazar:: Kumar, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Outcome in Philadelphia Chromosome Positive (Ph plus ) Adult ALL Patients (Pts) May Be More Determined by CD25 Expression Than by Ph Status Per Se
Yazar:: Paietta, E, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Yazar:: Rowe, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
Yazar:: Sive, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993).
Yazar:: Goldstone, A, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

The outcome of 267 Philadelphia positive adults in the international UKALL12/ECOG E 2993 study. Final analysis and the role of allogeneic transplant in those under 50 years.
Yazar:: Goldstone, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The impact of imatinib therapy on adult Philadelphia positive acute lymphoblastic leukaemia (ALL): Early results from the UKALL12/ECOG 2993 study
Yazar:: Patel, B, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
Yazar:: Fielding, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study.
Yazar:: Rai, L, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).
Yazar:: Rowe, J, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Minimal residual disease is a significant predictor of treatment failure in B lineage adult ALL: final results of the international trial UKALL XII:ECOG 2993
Yazar:: Patel, B, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Investigating Possible Binarity for GJ 229B
Yazar:: Alex R. Howe, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

The outcome of 551 1(st) CR transplants in adult ALL from the UKALL XII/ECOG 2993 study
Yazar:: Goldstone, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Prevalence of gallstones in 1,229 patients submitted to surgical laparoscopic treatment of GERD and esophageal achalasia: associated cholecystectomy was a safe procedure
Yazar:: Rubens Antonio Aissar SALLUM, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

PB1890: ZANUBRUTINIB IN ACALABRUTINIB-INTOLERANT PATIENTS (PTS) WITH B-CELL MALIGNANCIES
Yazar:: M. Shadman, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

SIRMIUM BISHOPS 1229–1534
Yazar:: Борис Стојковски
Baskı/Yayın Bilgisi: (2012-12-01)

СРЕМСКИ БИСКУПИ 1229–1534
Yazar:: Борис Стојковски
Baskı/Yayın Bilgisi: (2012-12-01)

Discovery of the Binarity of Gliese 229B, and Constraints on the System's Properties
Yazar:: Samuel Whitebook, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Yazar:: Goldstone, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Adult patients with acute lymphoblastic leukaemia (ALL) who relapse have a dismal outlook: Results from MRC UKALL XII/ECOG 2993 trial.
Yazar:: Chopra, R, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993.
Yazar:: Lazarus, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

ANTI-B-CELL THERAPY AT IMMUNE INFLAMMATORY RHEUMATIC DISEASES: EFFICACY AND TOLERABILITY IN 229 PATIENTS
Yazar:: L. P. Ananieva, ve diğerleri
Baskı/Yayın Bilgisi: (2014-10-01)